Cipla nurtures global vision for affordable drugs

The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...

June 13, 2012 | Wednesday | Analysis
Asia bioscience grows 11 percent, crosses $150 bn

During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...

June 21, 2013 | Friday | Analysis
Dr. Reddy's makes a mark in the US generics market

Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...

June 4, 2013 | Tuesday | Analysis
Aurobindo Pharma revamps strategy to accelerate growth

Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...

June 4, 2013 | Tuesday | Analysis
ResMed builds on partnerships for growth

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...

June 14, 2012 | Thursday | Analysis
Bioscience Industry clocks $139 bn, grows 8.37%

The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...

July 3, 2012 | Tuesday | Analysis
Sigma Pharma leverages on its pharmacy business

Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...

May 31, 2013 | Friday | Analysis
Shenzhen Neptunus invests in drug innovation

Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...

June 4, 2013 | Tuesday | Analysis
China holds largest pharma revenue share in APAC

In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...

June 11, 2012 | Monday | Analysis
China secures rank 1 in terms of total company revenues

China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...

June 18, 2013 | Tuesday | Analysis
China, Australia dominate APAC pharma market

The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...

June 11, 2012 | Monday | Analysis
China National Accord's R&D strategy begins to pay-off

China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...

May 31, 2013 | Friday | Analysis
India's 127-year-old ayurvedic leader clocks $847 mn

Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...

June 4, 2013 | Tuesday | Analysis
What were Asia's Top 20 bio companies in 2012?

During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...

June 19, 2013 | Wednesday | Analysis
What were the top 20 global M&A transactions of 2012?

A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...

June 12, 2013 | Wednesday | Analysis
Why did mergers & acquisitions plunge in APAC?

The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...

June 12, 2013 | Wednesday | Analysis
Sanjiu Medical keeps focus on R&D

Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...

June 21, 2012 | Thursday | Analysis
TCM leader Yunnan Baiyao rides on R&D strength

Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...

June 3, 2013 | Monday | Analysis